Pegavision Corporation (TPE:6491)

Taiwan · Delayed Price · Currency is TWD

335.00

-24.50 (-6.82%)

Jul 17, 2026, 1:30 PM CST

12.79% (1Y)

Market Cap	27.61B +18.6%
Revenue (ttm)	7.33B +9.7%
Net Income	1.61B -11.0%
EPS	20.40 -11.2%
Shares Out	76.80M
PE Ratio	17.62
Forward PE	14.66
Dividend	10.00 (2.74%)
Ex-Dividend Date	Aug 7, 2026

Volume	612,440
Open	353.00
Previous Close	359.50
Day's Range	333.00 - 356.50
52-Week Range	270.50 - 390.00
Beta	0.89
Analysts	Buy
Price Target	377.67 (+12.74%)
Earnings Date	Jul 29, 2026

About Pegavision

Pegavision Corporation manufactures and sells medical devices, and optical and precision instruments in Taiwan. It offers soft contact lenses. The company was founded in 2009 and is based in Taoyuan City, Taiwan. Pegavision Corporation operates as a subsidiary of Pegatron Corporation. [Read more]

Industry Medical Instruments & Supplies

Sector Healthcare

Founded 2009

Country Taiwan

Stock Exchange Taiwan Stock Exchange

Ticker Symbol 6491

Full Company Profile

Financial Performance

In 2025, Pegavision's revenue was 7.04 billion, an increase of 3.26% compared to the previous year's 6.82 billion. Earnings were 1.63 billion, a decrease of -11.07%.

Financial Statements

Analyst Summary

According to 6 analysts, the average rating for 6491 stock is "Buy." The 12-month stock price target is $377.67, which is an increase of 12.74% from the latest price.

Price Target

$377.67

(12.74% upside)

Analyst Consensus: Buy

Stock Forecasts